Results 221 to 230 of about 33,669,679 (309)
Basroparib inhibits YAP‐driven cancers by stabilizing angiomotin
Basroparib, a selective tankyrase inhibitor, suppresses Wnt signaling and attenuates YAP‐driven oncogenic programs by stabilizing angiomotin. It promotes AMOT–YAP complex formation, enforces cytoplasmic YAP sequestration, inhibits YAP/TEAD transcription, and sensitizes YAP‐active cancers, including KRAS‐mutant colorectal cancer, to MEK inhibition.
Young‐Ju Kwon +4 more
wiley +1 more source
Exosomal MicroRNAs as theranostic tools in type 2 diabetes and its complications: mechanistic insights and clinical implications. [PDF]
Vukelić I +9 more
europepmc +1 more source
Interrupting sedentary behaviour in the workplace through active breaks: a protocol study. [PDF]
Scoppolini Massini M +6 more
europepmc +1 more source
ChatGPT in liver transplantation: Current applications, limitations, and future directions. [PDF]
Avramidou E +5 more
europepmc +1 more source
Antimicrobial Resistance: The Answers. [PDF]
Millar BC +6 more
europepmc +1 more source

